Abstract

Therapies directed towards controlling hyperglycemia, the hallmark of type-2 diabetes mellitus, go a long way in managing diabetes and its related complications. Reducing glucose level through the inhibition of the relevant carbohydrate hydrolyzing enzymes is one among many routes in the management of diabetes. This study investigates the in vitro enzyme inhibitory and antioxidant properties of solvent-partitioned fractions of Spondias mombin and Mangifera indica leaves; which are used extensively in the treatment of diabetic patients locally. The leaves of S. mombin and M. indica were extracted with methanol and fractionated to obtain n-hexane (HF), ethyl acetate (EAF), n-butanol (BF), and aqueous (AF) fractions successively. The α-amylase and α-glucosidase inhibitory activities of fractions of S. mombin and M. indica leaves were investigated while the antioxidant activity of each fraction was analyzed using iron chelating and ABTS (2,2’-azino-bis(3-ethylbenzothiazoline)-6-sulphonic acid) radical scavenging assay. Our findings indicated that the ethyl acetate fraction of M. indica leaves contained a considerably higher (p < 0.05) amount of total phenolic, flavonoids, metal ion, and ABTS radical scavenging activity than the ethyl acetate fractions of S. mombin. Furthermore, the ethyl acetate fraction of M. indica had a considerably higher (p < 0.05) inhibitory effect on α-glucosidase (IC50 = 25.11 ± 0.01 μg mL−1), and α-amylase (IC50 = 24.04 ± 0.12 μg mL−1) activities than the S. mombin fraction. Hence, the inhibitory activities of S. mombin and M. indica leaves suggest that they are a potential source of orally active antidiabetic agents and could be employed to formulate new plant-based pharmaceutical and nutraceutical drugs to improve human health.

Highlights

  • Diabetes mellitus (DM) is a major public health problem

  • Since medicinal plants form a major part of human food, it is worthwhile to evaluate their inhibitory activity against hyperglycemia [2,3]

  • Several scientific studies have reported the antioxidant and antidiabetic activities of numerous medicinal plants including M. indica and S. mombin [36,37,38,39,40,41], to the best of our knowledge, this is the first report that directly compares the inhibitory effects of solvent-partitioned fractions of M. indica and S. mombin on α-amylase and α-glucosidase

Read more

Summary

Introduction

Diabetes mellitus (DM) is a major public health problem. The projected prevalence among adults in 2015 was 8.8%, affecting about 415 million adults. The prevalence of diabetes has been predicted to increase to about 10.4% by 2040 [1]. The recent exponential increase in the prevalence of this chronic disease requires a multiple therapeutic approach in the search of a real solution for diabetes and this includes the development of other alternative or complementary medications. Antioxidants 2018, 7, 73 traditional prescription and scientific investigation reveals optimum therapeutic efficacy of medicinal plants with a good margin of safety. Since medicinal plants form a major part of human food, it is worthwhile to evaluate their inhibitory activity against hyperglycemia [2,3]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call